Nitin Kamath and Kiran Mazumdar-Shaw raise concerns over India’s GLP-1 slowdown
Show Quick Read Key points generated by AI, verified by newsroom India's GLP-1 weight-loss drug market faces weaker-than-expected demand. Drugmakers ...
Show Quick Read Key points generated by AI, verified by newsroom India's GLP-1 weight-loss drug market faces weaker-than-expected demand. Drugmakers ...